customer service software
0

Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review

  • Published Date: 22 May 2019
  • Number of Pages: 45
  • Category: SWOT Analysis
  • Country: India

Ajanta Pharma Ltd (AJANTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company, which focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has a presence in cardiology, pain management, dermatology and ophthalmology therapy areas. It provides generics in developed markets of USA and branded generics in emerging countries such as India, Africa, CIS, Middle East and South East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and anti-malarial products to Africa and Global Fund. It operates subsidiaries in Mauritius, Philippines, Nigeria, the US and the UK. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.

Ajanta Pharma Ltd Key Recent Developments

Apr 03,2019: Ajanta Pharma announces resignation of Dr. Anil Kumar as Independent Director of the Company
Jan 30,2019: Ajanta Pharma reports Q3 FY 2019 consolidated result
Oct 31,2018: Ajanta Pharma reports Q2 FY 2019 consolidated result

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Publisher Name : GlobalData

 List of Figures
 Section 1 - About the Company
 Ajanta Pharma Ltd - Key Facts
 Ajanta Pharma Ltd - Key Employees
 Ajanta Pharma Ltd - Key Employee Biographies
 Ajanta Pharma Ltd - Major Products and Services
 Ajanta Pharma Ltd - History
 Ajanta Pharma Ltd - Company Statement
 Ajanta Pharma Ltd - Locations And Subsidiaries
 Head Office
 Other Locations & Subsidiaries
 Section 2 – Company Analysis
 Company Overview
 Ajanta Pharma Ltd - Business Description
 Product Category: Africa Institution sale
 Performance
 Product Category: Emerging Market Generic Sales
 Performance
 Product Category: The US Generic Sales
 Performance
 R&D Overview
 Ajanta Pharma Ltd - Corporate Strategy
 Ajanta Pharma Ltd - SWOT Analysis
 SWOT Analysis - Overview
 Ajanta Pharma Ltd - Strengths
 Ajanta Pharma Ltd - Weaknesses
 Ajanta Pharma Ltd - Opportunities
 Ajanta Pharma Ltd - Threats
 Ajanta Pharma Ltd - Key Competitors
 Section 3 – Company Financial Ratios
 Financial Ratios - Capital Market Ratios
 Financial Ratios - Annual Ratios
 Performance Chart
 Financial Performance
 Financial Ratios - Interim Ratios
 Financial Ratios - Ratio Charts
 Section 4 – Company’s Recent Developments
 Apr 03, 2019: Ajanta Pharma announces resignation of Dr. Anil Kumar as Independent Director of the Company
 Jan 30, 2019: Ajanta Pharma reports Q3 FY 2019 consolidated result
 Oct 31, 2018: Ajanta Pharma reports Q2 FY 2019 consolidated result
 Aug 30, 2018: Ajanta Pharma announces resignation of director
 Jul 31, 2018: Ajanta Pharma reports Q1 FY 2019 consolidated result
 Jul 27, 2018: Ajanta Pharma: Update on US FDA inspection
 May 02, 2018: Ajanta Pharma reports Q4 FY 2018 Consolidated Result
 Jan 25, 2018: Ajanta Pharma: Q3 Income from Operations at Rs. 587 cr., PAT at Rs. 147 cr.
 Jan 25, 2018: Ajanta Pharma reports Q3 FY 2018 Consolidated Result
 Section 5 – Appendix
 Methodology
 Ratio Definitions
 About GlobalData
 Contact Us
 Disclaimer



List Of Tables

 Ajanta Pharma Ltd, Key Facts
 Ajanta Pharma Ltd, Key Employees
 Ajanta Pharma Ltd, Key Employee Biographies
 Ajanta Pharma Ltd, Major Products and Services
 Ajanta Pharma Ltd, History
 Ajanta Pharma Ltd, Subsidiaries
 Ajanta Pharma Ltd, Key Competitors
 Ajanta Pharma Ltd, Ratios based on current share price
 Ajanta Pharma Ltd, Annual Ratios
 Ajanta Pharma Ltd, Annual Ratios (Cont...1)
 Ajanta Pharma Ltd, Annual Ratios (Cont...2)
 Ajanta Pharma Ltd, Interim Ratios
 Currency Codes
 Capital Market Ratios
 Equity Ratios
 Profitability Ratios
 Cost Ratios
 Liquidity Ratios
 Leverage Ratios
 Efficiency Ratios 



List Of Figures

 Ajanta Pharma Ltd, Performance Chart (2015 - 2019)
 Ajanta Pharma Ltd, Ratio Charts



Thoresen Thai Agencies PCL (TTA) - Financial and Strategic SWOT Analysis Review

View Report

Akamai Technologies Inc (AKAM) - Financial and Strategic SWOT Analysis Review

View Report

Telefonica SA (TEF) - Financial and Strategic SWOT Analysis Review

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)